Table S2. Study details.
Author | Year of publication | Hospital | Country | Study period | Patients | Device name | Follow-up (months) | Study quality |
---|---|---|---|---|---|---|---|---|
Acute/emergent | ||||||||
Sun | 2011 | Fuwai Hospital, Beijing Hospital, Beijing | China | 2003–2008 | 148 | Cronus | 42±18 | Medium |
Zhao | 2012 | Beijing Anzhen Hospital, Beijing | China | 2006–2011 | 24 | Cronus | 37±21 | Medium |
Jakob | 2013 | EVITA registry | International | 2005–2012 | 138 | E-Vita | NR | Low |
Shia | 2014 | First Affiliated Hospital Medical University, Shenyang | China | 2006–2011 | 155 | Cronus | 43±18 | Medium |
Shib | 2014 | First Affiliated Hospital Medical University, Shenyang | China | 2010–2012 | 54 | Cronus | 24±9 | Medium |
Zhang | 2014 | Changhai Hospital, Second Military Medical College, Shanghai | China | 2002–2010 | 88 | Cronus | 56±33 | Medium |
Katayama | 2015 | Hiroshima-City Asa General Hospital, Hiroshima | Japan | 1997–2012 | 120 | NR | 105±52 | Medium |
Chen | 2016 | Tianjin Medical University, Tianjin | China | 2009–2014 | 33 | NR | NR | Low |
Kobayashi | 2016 | Zurich University Hospital, Zurich | Switzerland | 2001–2012 | 34 | GoreTAG, Talent, E-Vita | 74±45 | Medium |
Aalaei-Andabili | 2017 | The University of Florida College of Medicine, Florida, USA | USA | 2010–2015 | 23 | GoreTAG, Valiant, TX2 | 17±17* | High |
Hu | 2017 | Renmin Hospital of Wuhan University, Hubei | China | 2008–2015 | 106 | Cronus | 43±22 | Medium |
Shrestha | 2017 | Hannover Medical School, Hannover | Germany | 2001–2016 | 100 | Chavan-Haverich, E-Vita, Thoraflex | 54±57* | Medium |
Yamane | 2017 | Akane-Foundation Tsuchiya General Hospital, Hiroshima | Japan | 2008–2015 | 24 | JOSG | 39±22* | Medium |
Berger | 2018 | University Heart Center Freiburg University, Freiburg | Germany | 2013–2017 | 31 | Thoraflex | 12±12 | Medium |
Goebel | 2018 | Robert-Bosch Hospital, Stuttgart | Germany | 2009–2016 | 72 | E-Vita | 38±21 | Medium |
Lopez Almodovar | 2018 | Virgen de la Salud Hospital, Toledo | Spain | 2011–2016 | 12 | E-Vita | 36±29 | Medium |
Ma | 2018 | Tongji Hospital, Wuhan | China | 2013–2015 | 132 | Cronus | 22±8* | Medium |
Roselli | 2018 | Cleveland Clinic, Ohio, USA | USA | 2009–2016 | 72 | GoreTAG | 28±25 | Low |
Kremer | 2019 | Heidelberg University Hospital, Heidelberg | Germany | 2006–2017 | 34 | E-Vita, Thoraflex | NR | Medium |
Lin | 2019 | Beijing Anzhen Hospital, Beijing | China | 2013–2014 | 53 | Cronus | 52±19 | Medium |
Qian | 2019 | Beijing Anzhen Hospital, Beijing | China | 2009–2012 | 218 | NR | 67±13 | Medium |
Tochii | 2019 | Fujita Health University, Toyoake | Japan | 2005–2017 | 22 | JOSG | 9±8 | Low |
Yamamoto | 2019 | Akita University Hospital, Akita | Japan | 2014–2018 | 108 | Frozenix | NR | Medium |
Chronic/emergent | ||||||||
Flores | 2006 | Hokkaido University School of Medicine, Hokkaido | Japan | 1996–2004 | 25 | Gianturco stent/Hemashield Gold graft | 35±13 | Low |
Uchida | 2010 | Hiroshima-City Asa General Hospital, Hiroshima | Japan | 1997–2008 | 58 | NR | 54±37 | Medium |
Sun | 2011 | FuWai Hospital, Beijing Hospital | China | 2003–2008 | 143 | Cronus | 43±19 | Medium |
Jakob | 2013 | EVITA registry | International | 2005–2012 | 142 | E-Vita | NR | Low |
Nakamura | 2014 | Miyazaki Prefectural Nobeoka Hospital, Nobeoka | Japan | 1998–2010 | 51 | NR | 51 | Medium |
Aalaei-Andabili | 2017 | The University of Florida College of Medicine, Florida, USA | USA | 2010–2015 | 25 | GoreTAG, Valiant, TX2 | 17±17* | High |
Shrestha | 2017 | Hannover Medical School, Hannover | Germany | 2001–2016 | 151 | Chavan-Haverich, E-Vita, Thoraflex | 43±42* | Medium |
Berger | 2018 | University Heart Center Freiburg University, Freiburg | Germany | 2013–2017 | 34 | Thoraflex | NR | Medium |
Zhong | 2018 | Beijing Anzhen Hospital, Beijing | China | 2010–2016 | 35 | Cronus | 49±22 | Medium |
Kremer | 2019 | Heidelberg University Hospital, Heidelberg | Germany | 2006–2017 | 34 | E-Vita, Thoraflex | NR | Medium |
Mixed | ||||||||
Leontyev | 2013 | Leipzig Heart Centre, Leipzig | Germany | 2006–2013 | 51 | E-Vita | 41±5 | Medium |
Weiss | 2016 | Hospital Hietzing, Vienna, Austria | Austria | 2005–2012 | 27 | E-Vita | 48±26 | Medium |
Mkalaluh | 2018 | European Medical School Oldenburg-Groningen, Oldenburg | Germany | 2001–2017 | 25 | E-Vita, Thoraflex | 26 | Low |
Tsagakis | 2018 | West German Heart Center Essen, Essen | Germany | 2005–2017 | 286 | E-Vita | NR | Low |
Alhussaini | 2019 | Assuit University, Assiut | Egypt | 2003–2016 | 48 | TX2, Valiant | 31±32* | Medium |
Chu | 2019 | 9 Canadian hospitals | Multi-Canadian | 2014–2017 | 40 | Thoraflex | 18±11 | Medium |
Dinato | 2019 | University of Sao Paulo Medical School, Sao Paulo | Brazil | 2009–2018 | 79 | E-Vita | 17±20 | Medium |
Kozlov | 2019 | Tomsk National Research Medical Centre, Tomsk | Russia | 2012–2018 | 26 | E-Vita | NR | Medium |
Leone | 2019 | Sant. Orsola-Malpighi Hospital, University of Bologna, Bologna | Italy | 2007–2018 | 282 | E-Vita, Thoraflex | NR | Medium |
Zhang | 2019 | FuWai Hospital, Beijing Hospital | China | 2010–2016 | 815 | Cronus | NR | Medium |
Device details: E-vita: Evita Open/Open Plus (Jotec Inc., Hechingen, Germany), Thoraflex: Vascutek Thoraflex hybrid graft (Vascutek, Scotland), Chavan-Haverich: Chavan-Haverich endograft (Curative GmbH, Dresden, Germany), Cronus: Cronus stented elephant trunk (MicroPort Medical Co. Ltd., Shanghai, China), GoreTAG: Gore TAG thoracic endoprosthesis (W. L. Gore and Associates, Flagstaff, USA), Talent: Talent thoracic stent graft (Medtronic/AVE, Santa Rosa, USA), Valiant: Valiant thoracic stent graft (Medtronic, Santa Rosa, USA), TX2: Zenith TX2 Dissection Endovascular Graft (Cook Medical Inc., Bloomington, USA), JSOG: J Graft open stent graft (Japan Lifeline Co., Tokyo, Japan), Frozenix: J Graft FROZENIX (Japan Lifeline Co Ltd., Tokyo, Japan), Gianturco: Gianturco stent (Cook Medical Inc., Bloomington, USA) with Hemashield Gold graft (Boston Scientific, Natick, USA). *, mean and standard deviation recalculated using methods of Wan et al. a, DOI: 10.1016/j.jtcvs.2013.10.058; b, DOI: 10.1016/j.jtcvs.2014.02.077.